{"transactions":[{"id":1912527,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":114150,"kind":"person","name":"Avat Xavier","position":1,"cik":"0001931345","reported_name":"Avat Xavier","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former CBO"}}],"security":"Common Stock","published_at":"2023-04-27T21:28:28.000Z","date":"2023-04-17","kind":"sale","planned":false,"acquired":false,"shares":14772,"price":64258,"value":949219176.0,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001931345-23-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000193134523000003/primary_doc.xml","form_type":"4"}},{"id":1923142,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":114150,"kind":"person","name":"Avat Xavier","position":1,"cik":"0001931345","reported_name":"Avat Xavier","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"FORMER CHIEF BUSINESS OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-07T21:00:16.000Z","date":"2023-04-05","kind":"exercise","planned":false,"acquired":false,"shares":84791,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares vested 1/48th of the first day of each month, commencing June 1, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The option expires 90 days following the termination of Mr. Avat's employment with the Company. Mr. Avat's employment terminated on April 7, 2023. While the box indicating that Mr. Avat is no longer subject to Section 16 has been checked, Mr. Avat remains subject to Section 16 through such date."}],"balance_after":0,"derivative":{"exercise_price":3.46,"expiration_date":"2023-07-06","underlying":"Common Stock","underlying_shares":84791},"source":{"system":"sec-edgar","filing":"0001415889-23-006365","document":"form4-04072023_050408.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588923006365/form4-04072023_050408.xml","form_type":"4"}},{"id":1923141,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":114150,"kind":"person","name":"Avat Xavier","position":1,"cik":"0001931345","reported_name":"Avat Xavier","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"FORMER CHIEF BUSINESS OFFICER"}}],"security":"Common Stock","published_at":"2023-04-07T21:00:16.000Z","date":"2023-04-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":70019,"price":4.19,"value":293379.61,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a \"net exercise\" of outstanding stock options. These shares were withheld by the Issuer for payment of the exercise price, based on the closing market price of the Issuer's common stock on April 5, 2023 of $4.19."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a \"net exercise\" of outstanding stock options. These shares were withheld by the Issuer for payment of the exercise price, based on the closing market price of the Issuer's common stock on April 5, 2023 of $4.19."}],"balance_after":14772,"source":{"system":"sec-edgar","filing":"0001415889-23-006365","document":"form4-04072023_050408.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588923006365/form4-04072023_050408.xml","form_type":"4"}},{"id":1923140,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":114150,"kind":"person","name":"Avat Xavier","position":1,"cik":"0001931345","reported_name":"Avat Xavier","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"FORMER CHIEF BUSINESS OFFICER"}}],"security":"Common Stock","published_at":"2023-04-07T21:00:16.000Z","date":"2023-04-05","kind":"exercise","planned":false,"acquired":true,"shares":84791,"price":3.46,"value":293376.86,"ownership":{"direct":true},"balance_after":84791,"source":{"system":"sec-edgar","filing":"0001415889-23-006365","document":"form4-04072023_050408.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588923006365/form4-04072023_050408.xml","form_type":"4"}},{"id":1923139,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":114150,"kind":"person","name":"Avat Xavier","position":1,"cik":"0001931345","reported_name":"Avat Xavier","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"FORMER CHIEF BUSINESS OFFICER"}}],"security":"Common Stock","published_at":"2023-04-07T21:00:16.000Z","date":"2023-03-28","kind":"sale","planned":false,"acquired":false,"shares":3000,"price":4.06,"value":12180.0,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-23-006365","document":"form4-04072023_050408.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588923006365/form4-04072023_050408.xml","form_type":"4"}},{"id":2210912,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":114150,"kind":"person","name":"Avat Xavier","position":1,"cik":"0001931345","reported_name":"Avat Xavier","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF BUSINESS OFFICER"}}],"security":"Common Stock","published_at":"2022-07-07T21:31:02.000Z","date":"2022-07-06","kind":"purchase","acquired":true,"shares":1000,"price":3.68,"value":3680.0,"ownership":{"direct":true},"balance_after":3000,"source":{"system":"sec-edgar","filing":"0001415889-22-007544","document":"form4-07072022_020749.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588922007544/form4-07072022_020749.xml","form_type":"4"}},{"id":2210911,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":114150,"kind":"person","name":"Avat Xavier","position":1,"cik":"0001931345","reported_name":"Avat Xavier","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF BUSINESS OFFICER"}}],"security":"Common Stock","published_at":"2022-07-07T21:31:02.000Z","date":"2022-06-29","kind":"purchase","acquired":true,"shares":1500,"price":3.7619,"value":5642.85,"ownership":{"direct":true},"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001415889-22-007544","document":"form4-07072022_020749.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588922007544/form4-07072022_020749.xml","form_type":"4"}},{"id":2255516,"issuer":{"id":5337,"kind":"organization","name":"CAPRICOR THERAPEUTICS, INC."},"owners":[{"id":114150,"kind":"person","name":"Avat Xavier","position":1,"cik":"0001931345","reported_name":"Avat Xavier","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF BUSINESS OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-27T01:33:29.000Z","date":"2022-05-23","kind":"grant","acquired":true,"shares":370000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest 1/48th of the first day of each month, commencing June 1, 2022, until the stock option becomes fully vested and exercisable. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting."}],"balance_after":370000,"derivative":{"exercise_price":3.46,"expiration_date":"2032-05-23","underlying":"Common Stock","underlying_shares":370000},"source":{"system":"sec-edgar","filing":"0001415889-22-005749","document":"form4-05262022_060515.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1133869/000141588922005749/form4-05262022_060515.xml","form_type":"4"}}]}